Patient centricity starts with communication and collaboration and these are the only ways to ensure people living with rare diseases like scleroderma will be able to access potentially transfo
The European pharmaceutical industry isn’t a faceless entity, it’s a community of more than 100,000 people all working together to improve the lives of people affected by illness.
Because its publicity that money just can’t buy, because it will attract a new breed of investors – and quite simply because it’s the right thing to do.
